ANTIMETABOLITE INDUCTION, HIGH-DOSE ALKYLATING AGENT CONSOLIDATION AND RETROVIRAL TRANSDUCTION OF THE MDR1 GENE INTO PERIPHERAL BLOOD PROGENITOR CELLS FOLLOWED BY INTENSIFICATION THERAPY WITH SEQUENTIAL PACLITAXEL AND DOXORUBICIN FOR STAGE 4 BREAST CANCER: